NLRX1 and Crohn disease: With independent effects in epithelial and immune cells, NLRX1 may serve as a potent therapeutic target for Crohn’s disease (CD) and ulcerative colitis (UC) due to synergisms of NLRX1 signaling in epithelial and immune cells.